Contemporary nano-architectured drugs and leads for ανβ3 integrin-based chemotherapy: Rationale and retrospect
The ανβ3 integrin antagonistic ligands, i.e., drugs as nano-architectural design-based nanomedicine, especially for cancer chemotherapy, are discussed.
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
De Gruyter
2021-12-01
|
| Series: | Nanotechnology Reviews |
| Subjects: | |
| Online Access: | https://doi.org/10.1515/ntrev-2022-0020 |